Takeda · 2 weeks ago
2026 Summer Internship Program: Operational Excellence Summer Intern
Takeda is a pharmaceutical organization that offers a Summer Internship Program focused on Operational Excellence. The Operational Excellence Summer Intern will gain practical experience in continuous improvement by supporting projects, data analysis, and process mapping while learning Lean methodologies and contributing to efficiency improvements.
BiotechnologyHealth CareManufacturingMedicalPharmaceutical
Responsibilities
Assist with process mapping, workflow documentation, and simple data analysis
Support problem-solving workshops and Kaizen events alongside OpEx team members
Prepare presentation materials to communicate findings and recommendations
Help identify improvement opportunities by observing and documenting current practices
Contribute to progress tracking and reporting on active OpEx initiatives
Shadow team members to learn how Lean and Six Sigma are applied in practice
Qualification
Required
Currently pursuing a Bachelor degree
Interest in continuous improvement, process excellence, or problem-solving methods
Strong analytical, organizational, and communication skills
Comfortable working in a team-oriented environment
Proficiency in Microsoft Excel, PowerPoint, or similar tools (basic data analysis skills a plus)
Must be authorized to work in the U.S. on a permanent basis without requiring sponsorship
Must be currently enrolled in a degree program graduating December 2026 or later
Able to work full time 40 hours a week during internship dates
Benefits
Paid sick time
Civic Duty paid time off
Participation at company volunteer events
Participation at company sponsored special events
Access to on-site fitness center (where available)
Commuter Benefit To offset your work-commute expenses, Takeda provides U.S. employees with a fixed monthly subsidy to be used for either public transportation (transit) or parking.
Company
Takeda
Takeda is a biopharmaceutical company that researches and develops pharmaceutical drugs.
Funding
Current Stage
Public CompanyTotal Funding
$2.46B2025-06-27Post Ipo Debt· $2.4B
2016-09-01Grant· $19.8M
2016-05-08Grant· $38M
Leadership Team
Recent News
2026-01-09
2026-01-08
Company data provided by crunchbase